RMD Q1 2021 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q1 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$752M+10.4% YoY

Gross Profit

$439M58.3% margin

Operating Income

$217M28.8% margin

Net Income

$178M23.7% margin

EPS (Diluted)

$1.22

QoQ Revenue Growth

-2.4%

Cash Flow

Operating Cash Flow

$144M

Free Cash Flow

$125M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$4.6B

Total Liabilities

$1.9B

Stockholders' Equity

$2.7B

Cash & Equivalents

$421M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$752M	$681M	+10.4%
Gross Profit	$439M	$405M	+8.3%
Operating Income	$217M	$171M	+26.8%
Net Income	$178M	$120M	+48.5%

Revenue Segments

Devices And Masks

$660M88%

Software As Service

$92M12%

Geographic Segments

Us Canada And Latin America

$495M66%

Combined Europe Asia And Other Markets

$257M34%